Home Overview Press Room Blog Publications For Students about us
Search

Medical Gene Transfer : Displaying 11-20 of 351


Dangers of an Unscientific Policy Process:
Why the UK’s legalization of “three-person babies” should not be the model for CRISPR
by Jessica Cussins, Biopolitical Times guest contributorOctober 25th, 2016The UK’s consideration of the science and public support for “mitochondrial replacement” may seem robust on its surface, but when it comes to CRISPR germline genome editing policy, we can and must do better.
First Spindle Nuclear Transfer Baby Has Low Mutant DNA Loadby Kate JohnsonMedscapeOctober 20th, 2016At the ASRM Scientific Congress, fertility doctors said they would continue using the mitochondrial manipulation procedure.
Crispr’s IPO doesn’t hit its targetby Robert WeismanThe Boston GlobeOctober 19th, 2016CRISPR Therapeutics' public offering raises half that of its rivals Editas & Intellia -- a sign that the market may be pulling back on genome editing stocks.
California stem cell agency approves $30 million to fast-track clinical trialsby David JensenThe Sacramento BeeOctober 19th, 2016Dubbed the new "pitching machine," CIRM's new $30 million effort is designed to accelerate clinical trials of stem cell therapies.
Reports of ‘three-parent babies’ multiplyby Sara ReardonNature NewsOctober 19th, 2016Claims of infants created using mitochondrial manipulation techniques in Mexico and China, and two pregnancies in the Ukraine, stir scientific and ethical debate.
CRISPR deployed to combat sickle-cell anaemiaby Heidi LedfordNature NewsOctober 12th, 2016Gene therapy aimed at a single-cell genetic condition shows some success in mice, while highlighting unknowns of human gene editing.
Comment on "3-person IVF" procedures for infertility reportedly conducted in Ukraine[Press statement]October 10th, 2016“These developments are another urgent sign that we need clear rules placing heritable human genetic modification off-limits on a national and international level.”
3-Person IVF Breaking News: Where Are the Advocates for the Public Interest? by Leah LowthorpBiopolitical TimesOctober 7th, 2016A baby created via 3-person IVF was delivered by US doctors in Mexico in order to avoid regulation. How has the media responded in the US and internationally?
CRISPR Embryos at Karolinska: Controversies Demand Oversightby Elliot HosmanOctober 7th, 2016Ongoing gene editing experiments in human embryos around the world underscore the need to prohibit modifying cells for use in human reproduction.
Don’t Miss This: The Story of CRISPR Told in a Comicby Kayla TolentinoOctober 6th, 2016Illustrator Andy Warner helps to break down the complexities of the still unraveling CRISPR gene editing story in his recent piece "Bad Blood."
Displaying 11-20 of 351  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760